Culpable 发表于 2025-3-25 06:20:12

http://reply.papertrans.cn/16/1548/154701/154701_21.png

尾随 发表于 2025-3-25 07:38:47

http://reply.papertrans.cn/16/1548/154701/154701_22.png

保留 发表于 2025-3-25 15:00:38

https://doi.org/10.1007/978-3-642-94232-7section of the channel which contains the specific binding sites for the calcium antagonists (see Chapter 4) it is appropriate now to briefly consider the chemistry of these drugs. Even the most superficial consideration of this aspect of the calcium antagonists cannot help but reveal:

reaching 发表于 2025-3-25 15:57:34

http://reply.papertrans.cn/16/1548/154701/154701_24.png

Tractable 发表于 2025-3-25 23:36:10

http://reply.papertrans.cn/16/1548/154701/154701_25.png

省略 发表于 2025-3-26 04:11:12

W. Schultz,G. Frhr. v. Seherr-Thoß (Chapter 7), coupled with its vascular selectivity (Chapter 8), this particular calcium antagonist would seem to be well suited for use in the long-term management of hypertensive patients and of patients with other cardiovascular disorders. It is worth considering, therefore, whether its pharmacok

mitral-valve 发表于 2025-3-26 07:16:51

http://reply.papertrans.cn/16/1548/154701/154701_27.png

Fibrinogen 发表于 2025-3-26 08:56:58

Evelyn H. Schulz,Frank P. Sempertl haemodynamics and function (Chapter 10), and before considering their usefulness as blood pressure lowering agents — particularly with respect to their long term use in the management of patients with essential hypertension (Chapter 14), the logical question which emerges now concerns the feasibil

Resistance 发表于 2025-3-26 15:19:39

http://reply.papertrans.cn/16/1548/154701/154701_29.png

frenzy 发表于 2025-3-26 16:49:11

http://reply.papertrans.cn/16/1548/154701/154701_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Amlodipine; Winifred G. Nayler Book 1993 Springer-Verlag Berlin Heidelberg 1993 Ca++-channel.Calcium-antagonist.PTCA.cardiovascular.hypert